Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

FibroGen Total Liabilities and Share Holders Equity 2013-2024 | FGEN

FibroGen total liabilities and share holders equity from 2013 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
  
FibroGen Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2024 $215
2023 $424
2022 $610
2021 $774
2020 $827
2019 $857
2018 $881
2017 $899
2016 $470
2015 $471
2014 $484
2013 $297
2012 $266
FibroGen Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2024-12-31 $215
2024-09-30 $264
2024-06-30 $293
2024-03-31 $366
2023-12-31 $424
2023-09-30 $460
2023-06-30 $515
2023-03-31 $539
2022-12-31 $610
2022-09-30 $609
2022-06-30 $687
2022-03-31 $746
2021-12-31 $774
2021-09-30 $851
2021-06-30 $809
2021-03-31 $787
2020-12-31 $827
2020-09-30 $812
2020-06-30 $808
2020-03-31 $824
2019-12-31 $857
2019-09-30 $894
2019-06-30 $915
2019-03-31 $812
2018-12-31 $881
2018-09-30 $856
2018-06-30 $870
2018-03-31 $868
2017-12-31 $899
2017-09-30 $895
2017-06-30 $543
2017-03-31 $442
2016-12-31 $470
2016-09-30 $486
2016-06-30 $499
2016-03-31 $443
2015-12-31 $471
2015-09-30 $499
2015-06-30 $541
2015-03-31 $436
2014-12-31 $484
2014-09-30 $0
2014-06-30 $0
2014-03-31 $0
2013-12-31 $297
2012-12-31 $266
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.034B $0.030B
FibroGen, Inc. is a research-based biotechnology company. It is focused on the discovery, development, and commercialization of therapeutic agents for treatment of anemia, fibrosis, cancer, and other serious unmet medical needs. The Company develops Roxadustat that is in Phase III clinical development for the treatment of anemia in chronic kidney disease; and FG-3019 which is in Phase II clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and liver fibrosis. FibroGen, Inc. is headquartered in San Francisco, California.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $98.106B 36.80
Zoetis (ZTS) United States $70.247B 26.59
Daiichi Sankyo, - (DSNKY) Japan $49.445B 25.16
Takeda Pharmaceutical (TAK) Japan $48.747B 10.79
Summit Therapeutics (SMMT) United States $20.720B 0.00
Sandoz Group AG (SDZNY) Switzerland $19.545B 0.00
Merck (MKKGY) Germany $18.346B 15.18
Shionogi (SGIOY) Japan $14.436B 0.00
United Therapeutics (UTHR) United States $13.288B 11.76
Neurocrine Biosciences (NBIX) United States $10.852B 33.34
IPSEN (IPSEY) France $9.920B 0.00
Orion OYJ (ORINY) Finland $8.948B 24.20
Corcept Therapeutics (CORT) United States $7.717B 58.69
Madrigal Pharmaceuticals (MDGL) United States $7.005B 0.00
Stevanato Group S.p.A (STVN) Italy $6.475B 41.12
Ono Pharmaceutical (OPHLF) Japan $5.988B 12.26
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.813B 0.00
Ionis Pharmaceuticals (IONS) United States $5.217B 0.00
Grifols, S.A (GRFS) Spain $5.054B 0.00
Soleno Therapeutics (SLNO) United States $3.755B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.161B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.029B 12.30
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.470B 13.51
Hypermarcas (HYPMY) Brazil $2.350B 15.46
Recursion Pharmaceuticals (RXRX) United States $2.291B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.200B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.868B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.813B 0.00
Indivior (INDV) United States $1.652B 7.01
Guardian Pharmacy Services (GRDN) United States $1.632B 0.00
Evotec AG (EVO) Germany $1.523B 0.00
ARS Pharmaceuticals (SPRY) United States $1.420B 180.75
Ocular Therapeutix (OCUL) United States $1.402B 0.00
Dyne Therapeutics (DYN) United States $1.348B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.122B 45.61
Enliven Therapeutics (ELVN) United States $1.006B 0.00
Ardelyx (ARDX) United States $0.988B 0.00
Harrow (HROW) United States $0.948B 0.00
Collegium Pharmaceutical (COLL) United States $0.888B 4.72
Avadel Pharmaceuticals (AVDL) Ireland $0.840B 0.00
Xencor (XNCR) United States $0.801B 0.00
AleAnna (ANNA) United States $0.758B 0.00
Xeris Biopharma Holdings (XERS) United States $0.737B 0.00
Cronos Group (CRON) Canada $0.709B 0.00
KalVista Pharmaceuticals (KALV) United States $0.674B 0.00
Organogenesis (ORGO) United States $0.670B 0.00
Akebia Therapeutics (AKBA) United States $0.641B 0.00
Bioventus (BVS) United States $0.601B 15.62
Savara (SVRA) United States $0.587B 0.00
USANA Health Sciences (USNA) United States $0.555B 11.92
Relay Therapeutics (RLAY) United States $0.554B 0.00
Regulus Therapeutics (RGLS) United States $0.520B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.519B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.474B 0.00
Verve Therapeutics (VERV) United States $0.463B 0.00
Elite Pharmaceuticals (ELTP) United States $0.453B 0.00
Altimmune (ALT) United States $0.444B 0.00
Zevra Therapeutics (ZVRA) United States $0.437B 0.00
Tourmaline Bio (TRML) United States $0.419B 0.00
CytoDyn (CYDY) United States $0.405B 0.00
Siga Technologies (SIGA) United States $0.402B 6.87
Oruka Therapeutics (ORKA) United States $0.401B 0.00
Heron Therapeutics (HRTX) United States $0.352B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.346B 20.60
Aquestive Therapeutics (AQST) United States $0.298B 0.00
Avita Medical (RCEL) United States $0.244B 0.00
Wellgistics Health (WGRX) United States $0.232B 0.00
ProKidney (PROK) United States $0.231B 0.00
Nature's Sunshine Products (NATR) United States $0.231B 27.15
Esperion Therapeutics (ESPR) United States $0.216B 27.25
OmniAb (OABI) United States $0.214B 0.00
Korro Bio (KRRO) United States $0.197B 0.00
Larimar Therapeutics (LRMR) United States $0.190B 0.00
MediWound (MDWD) Israel $0.186B 0.00
4D Molecular Therapeutics (FDMT) United States $0.174B 0.00
Aldeyra Therapeutics (ALDX) United States $0.168B 0.00
Inhibikase Therapeutics (IKT) United States $0.167B 0.00
Journey Medical (DERM) United States $0.162B 0.00
Nanobiotix S.A (NBTX) France $0.157B 0.00
Profound Medical (PROF) Canada $0.157B 0.00
Aclaris Therapeutics (ACRS) United States $0.156B 0.00
Lexeo Therapeutics (LXEO) United States $0.154B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.151B 46.62
Procaps Group, S.A (PROCF) Luxembourg $0.141B 0.00
Nektar Therapeutics (NKTR) United States $0.140B 0.00
Protara Therapeutics (TARA) United States $0.138B 0.00
Lyell Immunopharma (LYEL) United States $0.136B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.129B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.127B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
VAXART, INC (VXRT) United States $0.103B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.095B 0.00
OptiNose (OPTN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.094B 0.00
Achieve Life Sciences (ACHV) Canada $0.089B 0.00
Galectin Therapeutics (GALT) United States $0.088B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
Dominari Holdings (DOMH) United States $0.083B 0.00
Champions Oncology (CSBR) United States $0.080B 13.11
Unicycive Therapeutics (UNCY) United States $0.078B 0.00
Pyxis Oncology (PYXS) United States $0.078B 0.00
Context Therapeutics (CNTX) United States $0.078B 0.00
Cassava Sciences (SAVA) United States $0.078B 0.00
Fractyl Health (GUTS) United States $0.077B 0.00
Telomir Pharmaceuticals (TELO) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.077B 0.00
Nutriband (NTRB) United States $0.071B 0.00
Inotiv (NOTV) United States $0.068B 0.00
Karyopharm Therapeutics (KPTI) United States $0.063B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.063B 0.00
Assertio Holdings (ASRT) United States $0.062B 0.00
Vivani Medical (VANI) United States $0.062B 0.00
Gain Therapeutics (GANX) United States $0.061B 0.00
Metagenomi (MGX) United States $0.060B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Avalo Therapeutics (AVTX) United States $0.055B 0.00
PMV Pharmaceuticals (PMVP) United States $0.052B 0.00
ElectroCore (ECOR) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.046B 0.00
Acrivon Therapeutics (ACRV) United States $0.044B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.043B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.041B 0.00
SCYNEXIS (SCYX) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Prelude Therapeutics (PRLD) United States $0.039B 0.00
Rafael Holdings (RFL) United States $0.038B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
Surrozen (SRZN) United States $0.033B 0.00
PolyPid (PYPD) Israel $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
CASI Pharmaceuticals (CASI) China $0.024B 0.00
BioVie (BIVI) United States $0.022B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
VYNE Therapeutics (VYNE) United States $0.021B 0.00
Mannatech (MTEX) United States $0.020B 7.75
DURECT (DRRX) United States $0.019B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
Vivos Therapeutics (VVOS) United States $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Relmada Therapeutics (RLMD) United States $0.012B 0.00
TransCode Therapeutics (RNAZ) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 8.95
BioLineRx (BLRX) Israel $0.011B 0.00
Plus Therapeutics (PSTV) United States $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Carisma Therapeutics (CARM) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 3.19
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Jaguar Animal Health (JAGX) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Conduit Pharmaceuticals (CDT) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Klotho Neurosciences (KLTO) United States $0.005B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Incannex Healthcare (IXHL) Australia $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00